# Moderna said it is conducting early-stage research into vaccines targeting hantaviruses.

*biotech · news · 2026-05-08 · Benzinga*

## Key points

- Moderna is conducting early-stage research into mRNA vaccines targeting hantaviruses with US Army collaboration.
- In September 2024, Moderna began full-scale mRNA hantavirus vaccine development with Korea University's VIC-K.
- WHO has linked at least six confirmed hantavirus cases and three deaths to a cruise ship outbreak.
- Novavax reported $139.51 million in quarterly sales, significantly beating the $78.32 million estimate.

**Companies:** Moderna, Novavax
**Countries:** United States, South Korea

[Read the full story on Benzinga](https://www.benzinga.com/news/health-care/26/05/52424283/whats-going-on-with-novavax-stock-on-friday-2)

---

Canonical: https://newsio.io/n/d1a6e2d8-55a3-4039-aab1-48fb1fbd61b2/moderna-said-it-is-conducting-early-stage-research-into-vaccines-targeting-hanta
Summarized by Newsio from Benzinga. https://newsio.io/how-it-works